Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Further evidence of association between two NET single-nucleotide polymorphisms with ADHD

Abstract

The norepinephrine transporter (NET) gene is an attractive candidate gene for attention-deficit hyperactivity disorder (ADHD). Noradrenergic systems are critical to higher brain functions such as attention and executive function, which are defective in ADHD. The clinical efficacy of medications that target NET also supports its role in the etiology of ADHD. Here, we have applied a dense mapping strategy to capture all genetic variations within the NET gene in a large number of ADHD families (474 trios). As a result, we found association of the same alleles from two single-nucleotide polymorphisms (rs3785143 and rs11568324) previously identified in another large-scale ADHD genetic study (International Multisite ADHD Geneproject). Furthermore, the effect sizes were consistent across both studies. This is the first time that identical alleles of NET from different studies were implicated, and thus our report provides further evidence that the NET gene is involved in the etiology of ADHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Faraone S, Sergeant J, Gillberg C, Biederman J . The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003; 2: 104–113.

    PubMed  PubMed Central  Google Scholar 

  2. Gaub M, Carlson CL . Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997; 36: 1036–1045.

    Article  CAS  PubMed  Google Scholar 

  3. Biederman J, Faraone SV . Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237–248.

    Article  PubMed  Google Scholar 

  4. Cantwell DP . Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996; 35: 978–987.

    Article  CAS  PubMed  Google Scholar 

  5. Faraone SV, Doyle AE . The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2001; 10: 299–316, viii–ix.

    Article  CAS  PubMed  Google Scholar 

  6. Faraone SV . Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin N Am 2004; 27: 303–321.

    Article  Google Scholar 

  7. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT . Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990; 29: 526–533.

    Article  CAS  PubMed  Google Scholar 

  8. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992; 49: 728–738.

    Article  CAS  PubMed  Google Scholar 

  9. Thapar A, Hervas A, McGuffin P . Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence. Behav Genet 1995; 25: 537–544.

    Article  CAS  PubMed  Google Scholar 

  10. Levy F, Hay DA, McStephen M, Wood C, Waldman I . Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36: 737–744.

    Article  CAS  PubMed  Google Scholar 

  11. Smalley SL . Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder. Am J Hum Genet 1997; 60: 1276–1282.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Thapar A, Harrington R, Ross K, McGuffin P . Does the definition of ADHD affect heritability? J Am Acad Child Adolesc Psychiatry 2000; 39: 1528–1536.

    Article  CAS  PubMed  Google Scholar 

  13. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA et al. Molecular genetics of attention deficit hyperactivity disorder. Biol Psychiatry 2005; 57: 1313–1323.

    Article  CAS  PubMed  Google Scholar 

  14. Berridge CW, Waterhouse BD . The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 2003; 42: 33–84.

    Article  PubMed  Google Scholar 

  15. Arnsten AF, Li BM . Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005; 57: 1377–1384.

    Article  CAS  PubMed  Google Scholar 

  16. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT . Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 2002; 22: 389–395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Biederman J, Spencer TJ . Genetics of childhood disorders: XIX. ADHD, Part 3: is ADHD a noradrenergic disorder? J Am Acad Child Adolesc Psychiatry 2000; 39: 1330–1333.

    Article  CAS  PubMed  Google Scholar 

  18. Barr CL, Kroft J, Feng Y, Wigg K, Roberts W, Malone M et al. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am J Med Genet 2002; 114: 255–259.

    Article  PubMed  Google Scholar 

  19. De Luca V, Muglia P, Jain U, Kennedy JL . No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2004; 124: 38–40.

    Article  Google Scholar 

  20. McEvoy B, Hawi Z, Fitzgerald M, Gill M . No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am J Med Genet 2002; 114: 665–666.

    Article  PubMed  Google Scholar 

  21. Xu X, Knight J, Brookes K, Mill J, Sham P, Craig I et al. DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 115–118.

    Article  Google Scholar 

  22. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 67–72.

    Article  Google Scholar 

  23. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS et al. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci USA 2006; 103: 19164–19169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Yang L, Wang YF, Li J, Faraone SV . Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry 2004; 43: 1154–1158.

    Article  PubMed  Google Scholar 

  25. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 2006; 11: 934–953.

    Article  CAS  PubMed  Google Scholar 

  26. Biederman J, Faraone SV, Mick E, Williamson S, Wilens TE, Spencer TJ et al. Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry 1999; 38: 966–975.

    Article  CAS  PubMed  Google Scholar 

  27. Orvaschel H, Puig-Antich J . Schedule for Affective Disorders and Schizophrenia for School-Age Children: Epidemiologic Version. Nova University: Fort Lauderdale, FL, 1987.

    Google Scholar 

  28. Spitzer RL, Williams JB, Gibbon M, First MB . Structured Clinical Interview for DSM-III-R: Non-Patient Edition (SCID-NP, Version 1.0). American Psychiatric Press: Washington, DC, 1990.

    Google Scholar 

  29. Faraone SV, Biederman J, Milberger S . How reliable are maternal reports of their children's psychopathology? One-year recall of psychiatric diagnoses of ADHD children. J Am Acad Child Adolesc Psychiatry 1995; 34: 1001–1008.

    Article  CAS  PubMed  Google Scholar 

  30. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D . Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217–1223.

    Article  CAS  PubMed  Google Scholar 

  31. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579–593.

    Article  CAS  PubMed  Google Scholar 

  32. Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115–121.

    Article  PubMed  Google Scholar 

  33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M, Bender D et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007; 81: 559–575.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ et al. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 2004; 74: 348–356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM . Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002; 12: 207–215.

    Article  PubMed  Google Scholar 

  36. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313–1323.

    Article  CAS  PubMed  Google Scholar 

  37. Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ et al. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA 2006; 296: 1609–1618.

    Article  CAS  PubMed  Google Scholar 

  38. Lin PI, Vance JM, Pericak-Vance MA, Martin ER . No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007; 80: 531–538.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kim CH, Kim HS, Cubells JF, Kim KS . A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J Biol Chem 1999; 274: 6507–6518.

    Article  CAS  PubMed  Google Scholar 

  40. Hahn MK, Mazei-Robison MS, Blakely RD . Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol 2005; 68: 457–466.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful for the families and individuals who participated in this study. We thank Dr Keeley Brookes and Professor Philip Asherson for sharing their data with us, and Brian Galloway for technical assistance. This work was supported by National Institutes of Health (NIH) Grants HD37694, HD37999 and MH66877 to SVF and NARSAD Young Investigator Award to JWK. JWK is an NARSAD Sidney R Baer Jr Foundation Investigator.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J W Kim.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, J., Biederman, J., McGrath, C. et al. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD. Mol Psychiatry 13, 624–630 (2008). https://doi.org/10.1038/sj.mp.4002090

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4002090

Keywords

This article is cited by

Search

Quick links